What is ANI Pharmaceuticals's compensation and benefits?

ANI Pharmaceuticals (ANIP) reported compensation and benefits of $16.09M in Q1 2026.

How has ANI Pharmaceuticals's compensation and benefits changed year-over-year?

ANI Pharmaceuticals's compensation and benefits decreased by 27.8% year-over-year, from $22.3M to $16.09M.

What is the long-term trend for ANI Pharmaceuticals's compensation and benefits?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's compensation and benefits has grown at a 43.5% compound annual growth rate (CAGR), from $6.23M to $37.9M.

ANI Pharmaceuticals ANIP Compensation and benefits

Compensation and benefits at other companies

ViatrisVTRS

——

Viridian Therapeutics, Inc.VRDN

——

Aurinia PharmaceuticalsAUPH

——

Mirum Pharmaceuticals, Inc.MIRM

——

IncyteINCY

——

PfizerPFE

——

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.88B+18.3%

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's compensation and benefits?: ANI Pharmaceuticals (ANIP) reported compensation and benefits of $16.09M in Q1 2026.
How has ANI Pharmaceuticals's compensation and benefits changed year-over-year?: ANI Pharmaceuticals's compensation and benefits decreased by 27.8% year-over-year, from $22.3M to $16.09M.
What is the long-term trend for ANI Pharmaceuticals's compensation and benefits?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's compensation and benefits has grown at a 43.5% compound annual growth rate (CAGR), from $6.23M to $37.9M.